🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

With @ARTESIA_RCT presented at #AHA23 this AM, many are working to reconcile the positive results with those from NOAH AFNET 6 from #ESC2023. This meta-analysis does just that. The trials are totally consistent: ahajournals.org/doi/10.1161/CI… #EPeeps

Patients with long atrial high-rate episodes  ≥ 24 hours and stroke risk: don't miss the results of NOAH-AFNET 6 trial directly from #AHA2023! academic.oup.com/eurheartj/adva… #stroke #edoxaban #atrial #fibrillation #cardiotwitter @ESC_journals European Society of Cardiology

Do long episodes of device-detected #afib justify #anticoagulation? Check out the much-needed data of the #NOAHtrial substudy just published in the European Heart Journal 🤩doi.org/10.1093/eurhea… UKE Hamburg #Afib #AFNET #EHJ EHJ Editor-in-Chief

Enlightening editorial from Emma Svennberg on #NOAH vs. #ARTESIA in NEJM

Out now - our latest study on clinical presentation, shock severity and mortality in patients with de novo versus acute-on-chronic #HeartFailure-related #CardiogenicShock. Grateful, great collaborative effort! European Society of Cardiology Journals #EJHF doi.org/10.1002/ejhf.3…

🫵Pulsewave on pulseday!!🫵 Seid dabei: 1. März ist #pulseday! Das UHZ unterstützt diese wichtige Initiative! Hier bleibt keine Arrhythmie ungetastet!🎶 PULSEDAY AGEP EHRAPresident Laura Rottner Andreas Rillig Julian Chun Melanie Gunawardene

I am excited to present the 1st sub study from the The ARTESiA Trial 🇨🇦 at #EHRA2024 on Apr 9 in Berlin: Risk of stroke or systemic embolism according to baseline frequency and duration of subclinical #atrialfibrillation. What might SCAF pattern mean for clinical decision making?

Presented today at #ACC24: A randomized trial that enrolled patients with severe aortic stenosis at low or intermediate surgical risk showed that TAVI was noninferior to SAVR at 1 year. Read the full DEDICATE-DZHK6 trial results: nej.md/3TLx8MT

Congratulations on this important trial to @MoritzSeiffert and everyone involved! DZHK Germany University Center of Cardiovascular Science (UCCS) UKE Hamburg

🤩Great science and full house at #EHRA2024! Patients with device-detected #afib do not benefit from #anticoagulation! #NOAHtrial subanalysis just published: lnkd.in/eNCJVSS4 lnkd.in/edXpSr7M @JNikorowitsch Nina Becher Uli Schotten Daniel Scherr Renate Schnabel

JK Han MD Nassir Marrouche Gerhard Hindricks Rakesh Gopinath Dr. Helmut Pürerfellner Philipp Sommer BiykemBozkurt Andrew J Sauer MD The „wind of change“ for the #AF and #HF guidelines with class 1A indications for AF ablation goes out from Berlin once again #EHRA24 #ACC24 #ESC2024 #CASTLEHTx Nassir Marrouche Philipp Sommer Samuel Sossalla Prash Sanders Jason Andrade JK Han MD John Mandrola, MD HDZ NRW

This is my favorite part about medical science. When you think you know something, actual evidence kicks you in the shins

📣Just published on EHJ Editor-in-Chief European Society of Cardiology Journals 🤺🧠❤️🩸Great debate: device-detected subclinical atrial fibrillation should be treated like clinical atrial fibrillation #AHREs and OAC ⚖️ 🔗academic.oup.com/eurheartj/arti… Boriani Giuseppe Prash Sanders Emma Svennberg Isabelle Van Gelder

Atrial fibrillation burden: a new outcome predictor and therapeutic target. A Review article just published in #EHJ European Society of Cardiology European Society of Cardiology Journals #atrialfibrillation academic.oup.com/eurheartj/adva…

We are happy to share our ideas on AF burden. Let us know what you think!

Looking forward to #AFNET women power at #ESC2024 in #London! Don´t miss the inspiring talks of Prof. Renate Schnabel! #AFNET #stroke #anticoagulation #AI #cardiotwitter #risk University Center of Cardiovascular Science (UCCS)

🤩Brilliant presentation by Renate Schnabel in the last session of the #ESCCongress. Check out the just published results of a combined secondary analysis of the NOAH-AFNET 6 and ARTESiA trials. doi.org/10.1093/eurhea… University Center of Cardiovascular Science (UCCS) European Society of Cardiology Journals #EHJ #AFNET #afib

Can concomitant vascular disease modify the benefits and risks of anticoagulation in patients with device-detected atrial fibrillation? Read the combined analysis NOAH-AFNET 6 and ARTESiA trials in EHJ. doi.org/10.1093/eurhea… #ESCCongress #cardiotwitter European Society of Cardiology Journals European Society of Cardiology

#WomeninEP2024 in Munich. Great Start, excellent presentations and stimulating discussions💪🏻🥳Laura Rottner Victoria Johnson Doreen Schöppenthau (Schreiber) Andrea Sarkozy Micaela Ebert Ilaria My #Abbott🙏🏼